UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
CLINICAL RESEARCH

AGINKO

Digital health solutions for patient engagement and care

AGINKO logo

AGINKO

Clinical ResearchMarly, Switzerland

Digital health solutions for patient engagement and care

Visit WebsiteContact Company

About AGINKO

Specialising in osteoarticular and inflammation-focused research, AGINKO operates as a contract research organisation (CRO) with a defined focus that distinguishes it from broader-scope service providers. The company concentrates on the musculoskeletal segment, deploying a team of experienced musculoskeletal experts to guide orthopaedic products and compounds through pre-clinical and clinical development pathways.

Based in Marly, Switzerland, AGINKO Research AG serves clients across the pharmaceutical, biotechnology, and medical device industries. Its stated mission is to deliver high-quality pre-clinical laboratory services and clinical trial management with a commitment to both customer service and scientific rigour. The combination of pre-clinical and clinical capability within a single specialist organisation allows clients to progress compounds along the regulatory pathway without transferring to a separate provider at each stage.

The company's service portfolio spans preclinical research, including disease models; clinical research services; histology and laboratory services; medical consultation and referral; and consulting covering due diligence. Histology services represent a particular operational capability, with preclinical histology slide processing cited among the company's operational activities. Regulatory and clinical process guidance for orthopaedic compounds is a core offering, reflecting the organisation's specialist positioning in the osteoarticular field.

AGINKO serves clients globally across multiple countries, providing an international reach from its Swiss base. The company's focus on a defined therapeutic area, rather than a generalist CRO approach, positions it as a reference partner for organisations developing products in musculoskeletal and inflammatory conditions.

Further information is available at aginko.com.

Areas of Expertise

Clinical Trial ManagementInflammationPreclinical Research

Services & Capabilities

Clinical Trial ManagementInflammationPreclinical Research
Similar Companies

More in Clinical Research

4

4MCS

With a cumulative team experience of over 130 years in clinical trials and the pharmaceutical industry, 4MCS (4 Medical Clinical Solutions) operates as a patient-centred Site Management Organisation dedicated to improving the quality of research in healthcare. The organisation runs its own network of research sites and recruits volunteers from a patient population of over 10 million, giving sponsors direct access to well-characterised cohorts without the delays associated with conventional site activation. The therapeutic breadth across the site's active clinical trial programme spans respiratory conditions including asthma and COPD, cardiovascular disease areas such as atrial fibrillation and hypertension, metabolic and hepatic conditions including fatty liver disease, and a range of central nervous system and dermatological indications. Migraine, depression, general anxiety disorder, myasthenia gravis, lower back pain, psoriasis, and premenopausal effects on sexual health are among the specific areas where the organisation is actively recruiting or conducting clinical research. The patient-centred model that underpins the 4MCS approach prioritises participant experience alongside data quality, with a stated mission linked to improving patient quality of life through evidence generation. The organisation maintains dedicated disease and therapy area specialisms within its leadership and operations structure, supported by an established research site infrastructure across the United Kingdom. Further information is available at 4mcs.co.uk.

View profile
A

APCER Life Sciences

With a workforce comprising 100% healthcare professionals, including a 15% physician pool, APCER Life Sciences brings deep clinical and scientific expertise to every stage of the product lifecycle. The company is a specialist pharmacovigilance contract research organisation (CRO) serving pharmaceutical, biotech, and medical device partners across more than 100 markets worldwide. Over nearly two decades, APCER has built an integrated service model that spans the full spectrum of drug safety and regulatory requirements. Core capabilities include ICSR case processing, literature surveillance, aggregate reporting, signal management, and risk management programmes such as REMS. The company also provides QPPV and PSMF support, medical information through an integrated response centre, regulatory affairs, medical writing, and quality assurance, enabling sponsors to consolidate multiple functions under a single, accountable partner. Technology sits at the centre of the APCER model. The firm positions its solutions as fit-for-purpose technology-powered platforms, designed to meet the highest regulatory standards while offering clients scalable and flexible engagement models. This approach supports both small innovators and established organisations navigating complex global regulations. The company operates across North America, the United Kingdom, Europe, and Asia, and counts more than 90 customers within its client base. Its stated focus is on building strategic partnerships grounded in trust, transparency, and a customer-first mindset, with the overarching goal of helping safe and effective therapies reach patients worldwide. Further information is available at apcerls.com.

View profile
A

ACROSS Global

Rather than operating as a single centralised CRO, ACROSS Global Alliance is built on an alliance model that connects experienced local partners across more than 90 countries into a unified clinical trial delivery network. This structure allows sponsors to access genuine in-market expertise, regulatory knowledge, and cultural understanding at each site, rather than relying on generalist staff deployed from a central office. Clinical Trial Management Across Markets The alliance covers the full trial lifecycle, encompassing study design, site selection, patient recruitment, trial execution, specialised diagnostics, and patient-centric care services. Because each local partner operates within their own established regulatory environment, ACROSS Global is positioned to support complex, multi-country studies with greater agility than traditional CRO models permit. The framework is designed to reduce costs and accelerate timelines without sacrificing quality or compliance standards. Who ACROSS Global Serves Sponsors ranging from large pharmaceutical companies to emerging biotech organisations and academic institutions use the ACROSS Global network to enter new markets or scale existing programmes. The cost-effective structure is particularly relevant for organisations managing defined budgets across geographically dispersed studies, where local knowledge directly affects recruitment speed and site performance. The proprietary technology platform supports coordination across the partner network, providing visibility and consistency throughout each programme. Further information is available at across.global.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy